Literature DB >> 33498743

Revisiting Mitochondria Scored Cancer Progression and Metastasis.

Rohit Gundamaraju1, Wenying Lu2, Rishya Manikam3.   

Abstract

The Warburg effect has immensely succored the study of cancer biology, especially in highlighting the role of mitochondria in cancer stemness and their benefaction to the malignancy of oxidative and glycolytic cancer cells. Mitochondrial genetics have represented a focal point in cancer therapeutics due to the involvement of mitochondria in programmed cell death. The mitochondrion has been well established as a switch in cell death decisions. The mitochondrion's instrumental role in central bioenergetics, calcium homeostasis, and translational regulation has earned it its fame in metastatic dissemination in cancer cells. Here, we revisit and review mechanisms through which mitochondria influence oncogenesis and metastasis by underscoring the oncogenic mitochondrion that is capable of transferring malignant capacities to recipient cells.

Entities:  

Keywords:  OXPHOS; Warburg effect; cancer; cancer therapeutics; metastasis; mitochondria

Year:  2021        PMID: 33498743      PMCID: PMC7865825          DOI: 10.3390/cancers13030432

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  79 in total

1.  Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents.

Authors:  Santosh K Sandur; Haruyo Ichikawa; Gautam Sethi; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

2.  Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer.

Authors:  Katerina Rohlenova; Karishma Sachaphibulkij; Jan Stursa; Ayenachew Bezawork-Geleta; Jan Blecha; Berwini Endaya; Lukas Werner; Jiri Cerny; Renata Zobalova; Jacob Goodwin; Tomas Spacek; Elham Alizadeh Pesdar; Bing Yan; Maria Nga Nguyen; Magdalena Vondrusova; Margaryta Sobol; Petr Jezek; Pavel Hozak; Jaroslav Truksa; Jakub Rohlena; Lan-Feng Dong; Jiri Neuzil
Journal:  Antioxid Redox Signal       Date:  2016-08-22       Impact factor: 8.401

Review 3.  Mitochondrial dynamics and cancer.

Authors:  Stéphanie Grandemange; Sébastien Herzig; Jean-Claude Martinou
Journal:  Semin Cancer Biol       Date:  2008-12-24       Impact factor: 15.707

Review 4.  Mitochondria in cancer cells: what is so special about them?

Authors:  Vladimir Gogvadze; Sten Orrenius; Boris Zhivotovsky
Journal:  Trends Cell Biol       Date:  2008-03-04       Impact factor: 20.808

5.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

6.  Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors.

Authors:  Gray R Anderson; Suzanne E Wardell; Merve Cakir; Catherine Yip; Yeong-Ran Ahn; Moiez Ali; Alexander P Yllanes; Christina A Chao; Donald P McDonnell; Kris C Wood
Journal:  Nat Commun       Date:  2018-04-26       Impact factor: 14.919

7.  Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity.

Authors:  Dmitri Rozanov; Anton Cheltsov; Aaron Nilsen; Christopher Boniface; Isaac Forquer; James Korkola; Joe Gray; Jeffrey Tyner; Cristina E Tognon; Gordon B Mills; Paul Spellman
Journal:  PLoS One       Date:  2019-03-25       Impact factor: 3.240

Review 8.  Dysregulated Mitochondrial Dynamics and Metabolism in Obesity, Diabetes, and Cancer.

Authors:  Wenting Dai; Lei Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-03       Impact factor: 5.555

9.  Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.

Authors:  Qichao Huang; Lei Zhan; Haiyan Cao; Jibin Li; Yinghua Lyu; Xu Guo; Jing Zhang; Lele Ji; Tingting Ren; Jiaze An; Bingrong Liu; Yongzhan Nie; Jinliang Xing
Journal:  Autophagy       Date:  2016-04-28       Impact factor: 16.016

Review 10.  Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours.

Authors:  Sonia Missiroli; Mariasole Perrone; Ilaria Genovese; Paolo Pinton; Carlotta Giorgi
Journal:  EBioMedicine       Date:  2020-08-17       Impact factor: 8.143

View more
  3 in total

Review 1.  Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer.

Authors:  Sanjay Kumar; Rahail Ashraf; Aparna C K
Journal:  Cell Biol Toxicol       Date:  2021-10-18       Impact factor: 6.691

2.  Advances in the Knowledge of the Molecular Pathogenesis of High-Prevalence Tumors and Its Relevance for Their Future Clinical Management.

Authors:  Marta Rodríguez; Ion Cristóbal
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

3.  HMOX1 promotes lung adenocarcinoma metastasis by affecting macrophages and mitochondrion complexes.

Authors:  Bo Chen; Liyang Zhang; Hongshu Zhou; Wenrui Ye; Cong Luo; Liting Yang; Ning Fang; Anliu Tang
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.